Scott W. Rowlinson

4.7k total citations · 1 hit paper
55 papers, 3.7k citations indexed

About

Scott W. Rowlinson is a scholar working on Pharmacology, Genetics and Molecular Biology. According to data from OpenAlex, Scott W. Rowlinson has authored 55 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 20 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Scott W. Rowlinson's work include Inflammatory mediators and NSAID effects (21 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Estrogen and related hormone effects (11 papers). Scott W. Rowlinson is often cited by papers focused on Inflammatory mediators and NSAID effects (21 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Estrogen and related hormone effects (11 papers). Scott W. Rowlinson collaborates with scholars based in United States, Australia and United Kingdom. Scott W. Rowlinson's co-authors include Lawrence J. Marnett, Amit S. Kalgutkar, Kevin R. Kozak, Brenda C. Crews, Douglas C. Goodwin, Jeffery J. Prusakiewicz, Michael J. Waters, Ravi G. Kurumbail, William C. Stallings and James R. Kiefer and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Scott W. Rowlinson

54 papers receiving 3.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth

2016 431 citations Kendra Triplett, Susan E. Alters et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott W. Rowlinson United States	30	1.6k	1.3k	742	541	536	55	3.7k
Brenda C. Crews United States	35	2.2k 1.3×	1.2k 1.0×	1.3k 1.7×	677 1.3×	583 1.1×	84	4.6k
Sabine Grösch Germany	42	1.3k 0.8×	2.8k 2.3×	459 0.6×	429 0.8×	632 1.2×	84	5.2k
Ben S. Zweifel United States	31	4.0k 2.4×	1.6k 1.3×	1.4k 1.9×	1.0k 1.9×	1.6k 3.0×	41	7.2k
Dale E. Mais United States	32	886 0.5×	1.9k 1.6×	554 0.7×	335 0.6×	1.1k 2.1×	107	3.9k
Marco Macchia Italy	36	888 0.5×	2.1k 1.7×	1.2k 1.6×	189 0.3×	265 0.5×	226	4.3k
Filippo Minutolo Italy	38	563 0.3×	2.6k 2.1×	1.1k 1.5×	235 0.4×	541 1.0×	158	5.2k
Richard J. Kulmacz United States	38	2.8k 1.7×	1.5k 1.2×	695 0.9×	1.2k 2.2×	1.0k 1.9×	114	4.7k
Umberto M. Marinari Italy	39	368 0.2×	2.4k 2.0×	285 0.4×	498 0.9×	162 0.3×	114	4.8k
Robert W. Brueggemeier United States	34	858 0.5×	1.6k 1.3×	695 0.9×	88 0.2×	1.9k 3.6×	122	4.0k
Jih‐Hwa Guh Taiwan	40	721 0.4×	2.7k 2.1×	1.0k 1.4×	167 0.3×	100 0.2×	177	4.8k

Countries citing papers authored by Scott W. Rowlinson

Since Specialization

Citations

This map shows the geographic impact of Scott W. Rowlinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Rowlinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Rowlinson more than expected).

Fields of papers citing papers by Scott W. Rowlinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott W. Rowlinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Rowlinson. The network helps show where Scott W. Rowlinson may publish in the future.

Co-authorship network of co-authors of Scott W. Rowlinson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott W. Rowlinson. A scholar is included among the top collaborators of Scott W. Rowlinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott W. Rowlinson. Scott W. Rowlinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Badeaux, Mark, Annah S. Rolig, Melissa J. Kasiewicz, et al.. (2021). Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth. Cancer Immunology Research. 9(4). 415–429. 15 indexed citations

Karamitros, Christos S., et al.. (2021). Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase. Frontiers in Bioengineering and Biotechnology. 9. 793985–793985. 1 indexed citations

Grimes, Joseph M., Shaheer Khan, Mark Badeaux, et al.. (2020). Arginine depletion as a therapeutic approach for patients with COVID-19. International Journal of Infectious Diseases. 102. 566–570. 49 indexed citations

Wang, Xiaomeng, Christiaan F. Labuschagne, David Y. Mason, et al.. (2017). Oncogene-Selective Sensitivity to Synchronous Cell Death following Modulation of the Amino Acid Nutrient Cystine. Cell Reports. 18(11). 2547–2556. 206 indexed citations

Burrage, Lindsay C., Qin Sun, Sarah H. Elsea, et al.. (2015). Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency. Human Molecular Genetics. 24(22). 6417–6427. 38 indexed citations

Tate, Courtney M., Roberto Pallini, Lucia Ricci‐Vitiani, et al.. (2012). A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells. Cell Death and Differentiation. 19(10). 1644–1654. 56 indexed citations

Low, Jonathan, Michele Dowless, Tatiyana L. Shiyanova, et al.. (2010). Knockdown of Cancer Testis Antigens Modulates Neural Stem Cell Marker Expression in Glioblastoma Tumor Stem Cells. SLAS DISCOVERY. 15(7). 830–839. 12 indexed citations

Hu, Shuhong, Christine L. Gee, Catherine F. Latham, et al.. (2003). Recombinant expression of Munc18c in a baculovirus system and interaction with syntaxin4. Protein Expression and Purification. 31(2). 305–310. 6 indexed citations

Rowlinson, Scott W., et al.. (2002). Functional analysis of the molecular determinants of cyclooxygenase-2 acetylation by 2-acetoxyphenylhept-2-ynyl sulfide. Archives of Biochemistry and Biophysics. 409(1). 127–133. 4 indexed citations

10.

Rowland, Jennifer, N. J. Marshall, Kin‐Chuen Leung, et al.. (2002). A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays. Clinical Endocrinology. 56(4). 475–485. 16 indexed citations

11.

Boutaud, Olivier, Cynthia J. Brame, Pierre Chaurand, et al.. (2001). Characterization of the Lysyl Adducts of Prostaglandin H-Synthases That Are Derived from Oxygenation of Arachidonic Acid. Biochemistry. 40(23). 6948–6955. 26 indexed citations

12.

Kiefer, James R., Jennifer L. Pawlitz, Kirby T. Moreland, et al.. (2000). Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature. 405(6782). 97–101. 212 indexed citations

13.

Rowlinson, Scott W., Brenda C. Crews, Douglas C. Goodwin, et al.. (2000). Spatial Requirements for 15-(R)-Hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic Acid Synthesis within the Cyclooxygenase Active Site of Murine COX-2. Journal of Biological Chemistry. 275(9). 6586–6591. 65 indexed citations

14.

Kalgutkar, Amit S., Brenda C. Crews, Scott W. Rowlinson, et al.. (1999). Aspirin-like molecules that covalently inactivate cyclooxygenase-2. 12(7). 489–491. 50 indexed citations

15.

Kalgutkar, Amit S., et al.. (1999). Discovery of a New Class of Selective Cyclooxygenase-2 (COX-2) Inhibitor that Covalently Modifies the Isozyme. Advances in experimental medicine and biology. 469. 139–143. 2 indexed citations

16.

Sakal, Edna, Jeanne Grosclaude, Roni Shapira, et al.. (1997). Large-scale preparation and characterization of recombinant ovine placental lactogen. Journal of Endocrinology. 152(2). 317–327. 38 indexed citations

17.

Rowlinson, Scott W., Michael J. Waters, U.J. Lewis, & Ross Barnard. (1996). Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.. Endocrinology. 137(1). 90–95. 55 indexed citations

18.

Rowlinson, Scott W.. (1996). Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems. Endocrinology. 137(1). 90–95. 18 indexed citations

19.

Waters, Michael J., Scott W. Rowlinson, Richard Clarkson, et al.. (1994). Signal Transduction by the Growth Hormone Receptor. Experimental Biology and Medicine. 206(3). 216–220. 20 indexed citations

20.

Rowlinson, Scott W., Ross Barnard, Stan Bastiras, et al.. (1994). Evidence for Involvement of the Carboxy Terminus of Helix 1 of Growth Hormone in Receptor Binding: Use of Charge Reversal Mutagenesis to Account for Calcium Dependence of Binding and for Design of Higher Affinity Analogs. Biochemistry. 33(39). 11724–11733. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact